NCT05015517

Brief Summary

The aim of this study is to compare between the analgesic efficacy of ESP block and FIB in patients undergoing hip arthroplasty.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2021

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 10, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 20, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

August 20, 2021

Status Verified

August 1, 2021

Enrollment Period

1 year

First QC Date

August 10, 2021

Last Update Submit

August 19, 2021

Conditions

Keywords

Erector spinae blockFascia iliaca block

Outcome Measures

Primary Outcomes (1)

  • Total morphine requirements

    Amount of morphine required postoperatively

    24 hours postoperatively

Secondary Outcomes (3)

  • Visual analogue pain score

    at rest at 2, 4, 6, 12, 18, and 24 hours postoperatively

  • Time to first postoperative analgesic request

    24 hours postoperatively

  • Quadriceps muscle power strength

    at 6, 12 and 24 hours postoperatively

Study Arms (2)

ESPB Group

ACTIVE COMPARATOR

This group will receive ultrasound-guided erector spinae plane block and subarachnoid block.

Procedure: Erector spinae plain block

FIB Group

ACTIVE COMPARATOR

This group will receive supra-inguinal fascia iliaca block and subarachnoid block .

Procedure: Fascia Iliaca block

Interventions

Patients will be placed in the lateral position.Ultrasonography will be performed by an experienced anesthetist.The 4th lumbar vertebral level will be determined using the conventional method (imaginary line between two iliac crests). The low frequency convex probe (2-5MHz) will then be placed at the mid-vertebral line in the sagittal plane. It will be shifted from the midline, 3.5-4 cm lateral to the side of the surgery to visualize the erector spinae muscle and transverse process. Using the out-plane technique a 22G/80-mm block needle will be advanced until it reaches the transverse process. After negative aspiration, 0.5-1 ml of the prepared local anaesthetic solution (20 ml bupivacaine 0.5%, 10 ml lidocaine 2%) and 10 ml normal saline will be administered for hydrodissection to confirm correct location. The needle will be repositioned by pulling back a few millimeters if resistance occurred when injecting local anesthesia

ESPB Group

Patients will be placed in supine position. Ultrasonography will be performed by an experienced anesthetist using ultrasound device equipped with a low frequency (2-5 MHz) convex probe and an echogenic 21 G/ 10 cm needle will be used. The probe will be placed in the inguinal crease. Scan will be started laterally from the femoral artery and nerve in the inguinal crease to identify the Sartorius muscle. The muscle will then be traced until its origin at the anterior superior iliac spine is identified and the shadow of the bony of iliac crest \& iliacus muscle will be seen. Injection will be performed at the plane deep to the fascia iliaca and above the lateral part of the iliacus muscle. After negative aspiration, the prepared local anaesthetic solution (15 ml bupivacaine 0.5%, 15 ml normal saline) will be injected incrementally, aspirating every 5 ml.

FIB Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 65 years
  • ASA grade I to II
  • Patients scheduled for hip replacement surgeries under subarachnoid block (SAB) e.g. hip hemi-arthroplasty, total hip arthroplasty

You may not qualify if:

  • Patient refusal
  • Age below 18 or above 65 years.
  • ASA grade III to IV
  • Patients with known allergies to any of the drugs used.
  • Contraindication to SAB eg. Coagulopathy, infection at the injection site, severe cardiopulmonary disease, diabetic or other neuropathies.
  • Patients receiving opioids for chronic analgesic therapy
  • Inability to comprehend visual analogue scale (VAS)
  • Infection at site of erector spinae or fascia iliaca block.
  • Body mass index \>35 kg/m2

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

Study Officials

  • Ashraf RA Aswa, Professor

    Cairo University

    STUDY DIRECTOR

Central Study Contacts

Ahmed MA Moawad, Ass.lecturer

CONTACT

Sheren Refaat, A.Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
computer-generated sequence. Concealment will be achieved using opaque envelopes. All data will be collected blindly and the authors will perform the blocks without interference in data collection.
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

August 10, 2021

First Posted

August 20, 2021

Study Start

September 1, 2021

Primary Completion

September 1, 2022

Study Completion

October 1, 2022

Last Updated

August 20, 2021

Record last verified: 2021-08